Womens Gentle Laxative: Package Insert and Label Information

WOMENS GENTLE LAXATIVE- bisacodyl tablet, delayed release
DOLGENCORP, INC.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Active Ingredient (in each softgel)

Bisacodyl (USP) 5 mg

Purpose

Stimulant laxative

Uses

  • for temporary relief of occasional constipation and irregularity
  • this product generally produces bowel movement in 6 to 12 hours

Warnings

Do not use if you cannot swallow without chewing

Ask a doctor before use if you have

  • stomach pain, nausea or vomiting
  • a sudden change in bowel habits that lasts more than 2 weeks

When using this product

  • do not chew or crush tablet(s)
  • it may cause stomach discomfort, faintness and cramps
  • do not use within 1 hour after taking an antacid or milk

Stop use and ask a doctor if

  • you have rectal bleeding or no bowel movement after using this product. These could be signs of a serious condition.
  • you need to use a laxative for more than 1 week

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away 1(800)222-1222

Directions

  • take with a glass of water
adults and children 12 years and over 1 to 3 tablets in a single daily dose
children 6 to under 12 years of age 1 tablet in a single daily dose
children under 6 years of age ask a doctor

Other Information

  • store at 20-25°C (68-77°F)
  • protect from excessive humidity

Inactive ingredien ts

dextrose monohydrate, D&C Red #27, FD&C Blue #1, hypromellose, lactose monohydrate, lecithin, magnesium stearate, maltodextrin, methacrylic acid copolymer, methyl cellulose, pregelatinized starch, silica, sodium bicarbonate, sodium lauryl sulfate, talc, titanium dioxide, triacetin, triethyl citrate

Questions or comments?

1-888-333-9792

PRINCIPAL DISPLAY PANEL

Compare to the active ingredient in Dulcolax® Pink® Laxative Tablets*

Women’s Gentle Laxative
Bisacodyl USP 5 mg

• stimulant laxative
• gentle, overnight relief

25 tablets

Carton
(click image for full-size original)
WOMENS GENTLE LAXATIVE
bisacodyl tablet, delayed release
Product Information
Product Type HUMAN OTC DRUG Item Code (Source) NDC:55910-850
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
BISACODYL (DEACETYLBISACODYL) BISACODYL 25 mg
Inactive Ingredients
Ingredient Name Strength
HYPROMELLOSES
LACTOSE MONOHYDRATE
LECITHIN, SOYBEAN
MAGNESIUM STEARATE
MALTODEXTRIN
AMMONIUM ACRYLOYL DIMETHYLTAURATE/METHACRYLATE, DIMETHYLACRYLAMIDE AND METHACRYLIC ACID COPOLYMER, PPG-3 GLYCERYL TRIACRYLATE CROSSLINKED (100000 MW)
HYDROXYMETHYL CELLULOSE
STARCH, POTATO
SILICA DIMETHYL SILYLATE
SODIUM BICARBONATE
SODIUM LAURYL SULFATE
TALC
TITANIUM DIOXIDE
TRIACETIN
TRIETHYL CITRATE
DEXTROSE MONOHYDRATE
D&C RED NO. 27
FD&C BLUE NO. 1
Product Characteristics
Color pink Score no score
Shape ROUND Size 6mm
Flavor Imprint Code F
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:55910-850-25 25 TABLET, DELAYED RELEASE in 1 BLISTER PACK None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
OTC monograph not final part334 05/14/2022
Labeler — DOLGENCORP, INC. (068331990)

Revised: 11/2022 DOLGENCORP, INC.

DrugInserts.com provides trustworthy package insert and label information about marketed drugs as submitted by manufacturers to the US Food and Drug Administration. Package information is not reviewed or updated separately by DrugInserts.com. Every individual package label entry contains a unique identifier which can be used to secure further details directly from the US National Institutes of Health and/or the FDA.

As the leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. Our material is not intended as a substitute for direct consultation with a qualified health professional.

Terms of Use | Copyright © 2023. All Rights Reserved.